Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
Colofac MR. Modified release capsule.
| Pharmaceutical Form |
|---|
|
Modified release capsule. White, opaque, modified release capsule imprinted with “245”. |
Mebeverine hydrochloride 200 mg.
For excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mebeverine |
Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility. |
| List of Excipients |
|---|
|
Capsule content Modified release granules: Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose, methacrylic-acid ethyl acrylate copolymer 1:1 dispersion 30%, glycerol triacetate Capsule shell: Gelatine, titanium dioxide (E171), printing inks: shellac (E904), black iron oxide (E172), propylene glycol, concentrated ammonia solution, potassium hydroxide. |
Boxes containing 10 or 60 capsules in PVC-Al press through strips.
Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
PL 46302/0023
14/08/1998 / 04/07/2003
| Drug | Countries | |
|---|---|---|
| COLOFAC | Austria, Australia, Ireland, Malta, New Zealand, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
